Aether Bio Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 20

Aether Bio General Information

Description

Developer of a biocatalyst engineering technology designed to repurpose enzymes to create a new compound. The company's technology utilizes machine learning combined with high-throughput robotic laboratories to engineer enzymes rapidly and allows massively parallelized experimentation, generating datasets orders of magnitude larger, enabling researchers to manufacture complex and novel medical products at a fraction of the cost.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1455 Adams Drive
  • Suite 1630
  • Menlo Park, CA 94025
  • United States
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 1455 Adams Drive
  • Suite 1630
  • Menlo Park, CA 94025
  • United States

Aether Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aether Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC (Series A2) 03-Dec-2025 Completed Generating Revenue
4. Later Stage VC (Series A) 16-Aug-2023 Completed Generating Revenue
3. Debt - PPP 15-Apr-2020 Completed Generating Revenue
2. Accelerator/Incubator $9.9M Completed Generating Revenue
1. Early Stage VC 26-Nov-2018 $9.9M $9.9M Completed Generating Revenue
To view Aether Bio’s complete valuation and funding history, request access »

Aether Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-104
Series A-103
Series A-102
Series A-101
Series A-3
Series A-2
Series A-1
Series A
Seed 1 176,470 $0.000010 $0.17 $0.17 1x $0.17 0.19%
Seed 5,204,203 $0.000010 $2.67 $2.67 1x $2.67 5.66%
To view Aether Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aether Bio Patents

Aether Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4743786-A1 Use of generative artificial intelligence for protein engineering Pending 13-Jul-2023
WO-2025014634-A1 Use of generative artificial intelligence for protein engineering Inactive 13-Jul-2023
EP-4463546-A2 Systems and methods for engineering protein activity Pending 10-Jan-2022
EP-4463546-A4 Systems and methods for engineering protein activity Pending 10-Jan-2022
US-20240013854-A1 Systems and methods for engineering protein activity Pending 10-Jan-2022 G16B40/20
To view Aether Bio’s complete patent history, request access »

Aether Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aether Bio Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
4DX Ventures Venture Capital Minority
Contrary (San Francisco) Venture Capital Minority
Gaingels Venture Capital Minority
House Capital Venture Capital Minority
Modi Ventures Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Aether Bio FAQs

  • When was Aether Bio founded?

    Aether Bio was founded in 2017.

  • Where is Aether Bio headquartered?

    Aether Bio is headquartered in Menlo Park, CA.

  • What is the size of Aether Bio?

    Aether Bio has 38 total employees.

  • What industry is Aether Bio in?

    Aether Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Aether Bio a private or public company?

    Aether Bio is a Private company.

  • What is Aether Bio’s current revenue?

    The current revenue for Aether Bio is .

  • How much funding has Aether Bio raised over time?

    Aether Bio has raised $73.9M.

  • Who are Aether Bio’s investors?

    4DX Ventures, Contrary (San Francisco), Gaingels, House Capital, and Modi Ventures are 5 of 20 investors who have invested in Aether Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process